Transgene Biotek Ltd Share Price Today - Transgene Biotek Ltd Stock Price Live NSE/BSE

Transgene Biotek Ltd

NSE: BSE: 526139

₹2.72

(-2.16%)

Sun, 10 May 2026, 11:52 am

MTF 5xInvest in Transgene Biotek Ltd with 5x Leverage Buy with MTF

Market Cap186.79M

PE Ratio0

Dividend0

24.5K

Transgene Biotek Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
23.49
Net Profit
-0.68
P/B
2.54
Sector P/E
60.76
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.62
Interest Cover (Industry)
3303
ROCE (Industry)
0.01
RONW (Industry)
0.01
ROE
0
ROCE
0
Debt/Equity
1.38
EPS (TTM)
0
Dividend Yield
0
Book Value
1.22
Interest Cover
-1.83

Analysis

all

Pros

Transgene Biotek's level of debt (31.6%) compared to net worth is satisfactory (less than 40%).
Low level of unsold assets.
Transgene Biotek is good value based on assets compared to the IN Biotechs industry average.
526139 outperformed the Market in India which returned -14.5% over the past year.
BSE:526139 is up 45.2% outperforming the Biotechs industry which returned 18.2% over the past month.

Cons

Unable to evaluate Transgene Biotek's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Transgene Biotek's dividend against the top 25% market benchmark as the company has not reported any payouts.
Transgene Biotek's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
Transgene Biotek has less than a year of cash runway if free cash flow continues to grow at historical rates of 22% each year.
Transgene Biotek has less than a year of cash runway based on current free cash flow.

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	23.64	23.64	23.64	23.64	23.64
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	76.36	76.36	76.36	76.36	76.36
Government	0	0	0	0	0

Technical Analysis

RSI

61.35

MACD

0.13

50 DMA

2.64

200 DMA

3.35

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	5.07	3.85	3.29	2.63	2.07	1.41	0.19
Fibonacci	3.85	3.39	3.10	2.63	2.17	1.88	1.41
Camarilla	3.06	2.94	2.83	2.63	2.61	2.50	2.38

Pivots Level: Classic

+2.44

5.07

+1.22

3.85

+0.65

3.29

2.63

Pivot Point

LTP: 3.10

-0.57

2.07

-1.22

1.41

-2.44

0.19

Moving Average

SMAEMA

Period

Value

10-EMA
2.97
20-EMA
2.86
30-EMA
2.78
50-EMA
2.72
100-EMA
2.82
200-EMA
3.27

Announcement Date	Purpose	Action
13 Feb 2026	board-meetings	Quarterly Results
08 Dec 2025	egm
14 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
14 Nov 2025	agm
12 Nov 2024	agm
14 Nov 2023	agm
13 Aug 2022	agm
14 Aug 2021	agm

Transgene Biotek Ltd

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd

Aster DM Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd

Transgene Biotek Ltd About

Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc

Industry

Miscellaneous

Founded

1990

Headquarters

CEO

K Koteswara Rao

Employees

Contact

Website

http://www.transgenebiotek.com

info@transgenebiotek.com

Phone

Location

Plot No 69 & 70 IDA Bollaram, , Sangareddy, Telangana, 502325

Year	History
1993	The company commenced commercial production.
2011	The company set up a wholly-owned subsidiary in Hong Kong named Transgene Biotek HK Ltd.
2012	Transgene readied to launch one of its block-buster drugs - TrabiDHA (DHA) formulations.
2013	Transgene signed a Joint Venture agreement with Atral Cipan of Portugal involving the technology transfer of Tacrolimus. Transgene Biotek became the worldâs first company to create and launch 50% algal DHA oil and 20% algal DHA powder.
2014	Sri Sarang Subhash Puranik and Shyam Shankar Das were appointed as Directors of the company.

Client Name	Order Side	QTY	Avg Price	Date
GEETANJALI INVESTMENTS	Sell	896281	8.16	01 Dec 2023
SAHASRAR CAPITAL PRIVATE LIMITED	Buy	371570	7.83	01 Dec 2023
MAYUR VIJAY PATWA	Buy	401000	8.19	01 Dec 2023
SAHASRAR CAPITAL PRIVATE LIMITED	Buy	350000	9.12	24 Nov 2023
GEETANJALI INVESTMENTS	Sell	716159	9.1	24 Nov 2023
GEETANJALI INVESTMENTS	Sell	447728	8.7	23 Nov 2023
SH AS ENTERPRISES LLP	Buy	400000	3.36	27 Mar 2014
GEETANJALI INVESTMENTS	Buy	1785488	2.02	19 Jun 2013
DIPESH NALINBHAI DAVE	Buy	1000000	2.03	19 Jun 2013
GEETANJALI INVESTMENTS	Buy	3445350	1.95	18 Jun 2013

Transgene Biotek Ltd News

Transgene Biotek Confirms Non-Large Corporate Status

Transgene Biotek Limited confirms to BSE that it does not meet SEBI's Large Corporate criteria as per November 2018 circular, maintaining its classification outside the large entity category.

13 Apr 2026

companies

Transgene Biotek Files Non-Applicability Notice

Transgene Biotek Limited informed BSE that SEBI Regulation 32(1) requirements for Q4FY26 are not applicable as the company had no public or rights issues during the quarter ended March 31, 2026.

13 Apr 2026

companies

Transgene Biotek Confirms Non-Applicability of SEBI Reg

Transgene Biotek Limited informs BSE that SEBI LODR Regulation 57(5) is not applicable for Q4 FY26 as the company has not issued any non-convertible securities.

13 Apr 2026

companies

Transgene Biotek Confirms Non-Applicability of SEBI Reg

Transgene Biotek Limited informs BSE that SEBI LODR Regulation 57(5) is not applicable for Q4 FY26 as the company has not issued any non-convertible securities.

13 Apr 2026

companies

Transgene Biotek Files Share Transfer Compliance

Transgene Biotek Limited submits compliance certificate to BSE confirming share transfer facility maintenance through SEBI-approved registrar Bigshare Services Private Limited.

13 Apr 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800